Connexin Mutations and Hereditary Diseases

Area of Science:

• Genetics and Molecular Biology
• Cell Biology
• Pathology

Background:

• Inherited diseases linked to connexin mutations affect diverse organs, including hereditary deafness, cataracts, heart conditions, skin disorders, and Charcot-Marie-Tooth disease (CMT1X).
• Connexins exhibit high structural homology, suggesting common pathogenic mechanisms across various connexin-related hereditary diseases.
• Animal models (knockout and knock-in) are crucial for investigating the pathology and pathogenesis of these multi-organ diseases.

Purpose of the Study:

• To analyze similarities and differences in pathology and pathogenesis of connexin-related hereditary diseases using animal models.
• To identify shared pathogenic mechanisms underlying diseases affecting the ear, eye, heart, skin, and peripheral nerves.
• To investigate the role of dominant connexin mutations and their implications for gene therapy.

Main Methods:

• Comparative analysis of pathology and pathogenesis in various animal models of connexin-related diseases.
• In vivo and in vitro studies to assess cellular proliferation, differentiation, and gap junction function.
• Identification and characterization of specific connexin mutations, including dominant gain-of-function variants.

Main Results:

• Connexin mutations in gap junction genes impact cellular proliferation and differentiation in affected organs.
• Specific dominant mutations (e.g., Cx43 p.Gly60Ser, Cx32 variants) function as gain-of-function in vivo, contributing to disease onset.
• Complete loss or altered gap junctional function, including permeability and electrical activity, was observed.

Conclusions:

• Connexin mutations disrupt cellular processes and gap junction function, leading to multi-organ hereditary diseases.
• Dominant gain-of-function mutations represent a significant mechanism in these inherited disorders, complicating gene therapy approaches.
• Understanding these mechanisms is vital for developing effective treatments for connexin-related hereditary diseases.